Clincosm LogoSign in Get a demo

Waldenstrom Macroglobulinemia

Showing 51 - 75 of 154
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Adult Grade III Lymphomatoid Granulomatosis, B-cell Chronic Lymphocytic Leukemia, Contiguous Stage II Adult Diffuse Large Cell

Active, not recruiting
  • Adult Grade III Lymphomatoid Granulomatosis
  • +71 more
  • Chicago, Illinois
  • +5 more
Oct 8, 2021

Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma

Terminated
Has Results
  • Adult Grade III Lymphomatoid Granulomatosis
  • +116 more
  • brentuximab vedotin
  • +2 more
  • Chicago, Illinois
  • +2 more
Aug 30, 2021

Waldenstrom Macroglobulinemia Trial in New York (Epratuzumab (hLL2- anti-CD22 humanized antibody))

Terminated
  • Waldenstrom Macroglobulinemia
  • Epratuzumab (hLL2- anti-CD22 humanized antibody)
  • New York, New York
  • +1 more
Aug 12, 2021

Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Chronic Lymphocytic Leukemia, Recurrent Extranodal Marginal Zone Lymphoma of

Active, not recruiting
  • Recurrent B-Cell Non-Hodgkin Lymphoma
  • +22 more
  • Scottsdale, Arizona
  • +1 more
Aug 10, 2021

Waldenström Macroglobulinemia Trial in Vandoeuvre les Nancy (Blood or bone marrow samples)

Completed
  • Waldenström Macroglobulinemia
  • Blood or bone marrow samples
  • Vandoeuvre les Nancy, France
    CHRU Nancy
Aug 1, 2021

Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, Waldenstrom Macroglobulinemia Trial in Milwaukee

Enrolling by invitation
  • Monoclonal Gammopathy of Undetermined Significance
  • +6 more
    • Milwaukee, Wisconsin
      Aurora Health Care
    Jul 20, 2021

    Lymphoma, Non-Hodgkin, Lymphoma, Follicular, Lymphoma, Mantle-Cell Trial in Providence (Rituximab, Bendamustine, Vincristine

    Active, not recruiting
    • Lymphoma, Non-Hodgkin
    • +5 more
    • Providence, Rhode Island
      Rhode Island Hospital and The Miriam Hospital
    Jul 19, 2021

    B-cell Lymphoma, Chronic Lymphocytic Leukaemia, Waldenström Macroglobulinemia Trial in United Kingdom (BI-1206 single agent dose

    Completed
    Has Results
    • B-cell Lymphoma
    • +2 more
    • BI-1206 single agent dose escalation phase
    • +3 more
    • Leicester, England, United Kingdom
    • +4 more
    Jun 17, 2021

    Waldenström Macroglobulinemia Trial in United States (Zanubrutinib)

    No longer available
    • Waldenström Macroglobulinemia
    • Mobile, Alabama
    • +19 more
    Jun 8, 2021

    Hyperviscosity Syndrome, Waldenstrom Macroglobulinemia Trial in Amiens (other, biological, procedure)

    Recruiting
    • Hyperviscosity Syndrome
    • Waldenstrom Macroglobulinemia
    • fundoscopic picture
    • +2 more
    • Amiens, France
      CHU Amiens
    May 19, 2021

    Waldenstrom's Disease, Waldenstrom Macroglobulinemia Trial in Amiens (bone marrow sample, blood sample)

    Recruiting
    • Waldenstrom's Disease
    • Waldenstrom Macroglobulinemia
    • bone marrow sample
    • blood sample
    • Amiens, France
      CHU Amiens
    May 17, 2021

    Non-Hodgkin Lymphoma, Burkitt's Lymphoma, Chronic Lymphocytic Leukemia Trial in Italy, United Kingdom, United States (ADCT-402)

    Completed
    Has Results
    • Non-Hodgkin Lymphoma
    • +8 more
    • La Jolla, California
    • +10 more
    Apr 27, 2021

    Waldenstrom Macroglobulinemia Trial in United Kingdom (Pembrolizumab, Rituximab)

    Recruiting
    • Waldenstrom Macroglobulinemia
    • Plymouth, Devon, United Kingdom
    • +7 more
    May 17, 2021

    Adult Grade III Lymphomatoid Granulomatosis, B-cell Chronic Lymphocytic Leukemia, Contiguous Stage II Adult Burkitt Lymphoma

    Completed
    Has Results
    • Adult Grade III Lymphomatoid Granulomatosis
    • +88 more
    • Detroit, Michigan
      Barbara Ann Karmanos Cancer Institute
    Apr 14, 2021

    Covid-19 Vaccine Responsiveness in MM and Waldenstrom

    Not yet recruiting
    • Multiple Myeloma
    • +3 more
      • Boston, Massachusetts
      • +1 more
      Mar 31, 2021

      Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With

      Active, not recruiting
      • Adult Acute Lymphoblastic Leukemia in Remission
      • +46 more
      • Philadelphia, Pennsylvania
        Thomas Jefferson University
      Feb 10, 2021

      Lymphoma, T-Cell, Cutaneous, Lymphoma, T-Cell, Peripheral, Chronic Lymphocytic Leukemia Trial in Ann Arbor (Pacritinib)

      Terminated
      • Lymphoma, T-Cell, Cutaneous
      • +6 more
      • Ann Arbor, Michigan
        University of Michigan Rogel Cancer Center
      Jan 20, 2021

      Genomic, Transcriptomic and Functional Characteristics of Tumor

      Not yet recruiting
      • Monoclonal Gammopathy of Undetermined Significance
      • +2 more
        • Paris, France
          Service de Médecine Interne
        Jan 8, 2021

        Waldenstrom Macroglobulinemia Trial in United Kingdom (Dexamethasone, cyclophosphamide, rituximab, Rituximab, ibrutinib)

        Recruiting
        • Waldenstrom Macroglobulinemia
        • Dexamethasone, cyclophosphamide, rituximab
        • Rituximab, ibrutinib
        • Bournemouth, United Kingdom
        • +6 more
        Dec 16, 2020

        Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma Trial in

        Completed
        Has Results
        • Adult Nasal Type Extranodal NK/T-cell Lymphoma
        • +35 more
        • Akt inhibitor MK2206
        • laboratory biomarker analysis
        • Houston, Texas
          M D Anderson Cancer Center
        Oct 14, 2020

        Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma Trial in

        Completed
        Has Results
        • Adult Nasal Type Extranodal NK/T-cell Lymphoma
        • +18 more
        • Scottsdale, Arizona
        • +1 more
        Sep 28, 2020

        Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Lymphoplasmacytoid Lymphoma Trial in United States (SNS-062)

        Terminated
        • Chronic Lymphocytic Leukemia
        • +7 more
        • Orange, California
        • +10 more
        Oct 15, 2020

        Waldenström Macroglobulinemia Trial in Tianjin (Zanubrutinib,Ixazomib and Dexamethasone)

        Recruiting
        • Waldenström Macroglobulinemia
        • Zanubrutinib,Ixazomib and Dexamethasone
        • Tianjin, Tianjin, China
          Institute of Hematology & Blood Diseases Hospital
        Jul 8, 2020

        B-cell Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Diffuse Well-differentiated Lymphocytic Lymphoma Trial in

        Completed
        Has Results
        • B-cell Chronic Lymphocytic Leukemia
        • +9 more
        • Stanford, California
        • +15 more
        May 14, 2020

        Chronic Lymphocytic Leukemia, Waldenstrom Macroglobulinemia, Mantle Cell Lymphoma Trial (Ibrutinib, LY3214996)

        Withdrawn
        • Chronic Lymphocytic Leukemia
        • +3 more
        • (no location specified)
        Feb 3, 2020